Updated Story CMS Administrator Andrew Slavitt and FDA Commissioner Robert Califf on Wednesday sent a letter to a key committee saying they are committed to work toward incorporation of unique device identifier (UDI) collection in claim forms, a key element of FDA's proposed device surveillance system. The July 13 letter, sent to Gary Beatty, chair of the Accredited Standards Committee X12, while marking a shift from CMS' previous reluctance to support UDIs on claims, stresses a need...